 SOUTH SAN FRANCISCO, Calif., April 28, 2021 GLOBE NEWSWIRE -- NGM Biopharmaceuticals, Inc. NGM Nasdaq: NGM, a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced today the nomination of Roger M. Perlmutter, M.D., Ph.D., to stand for election to the companys board of directors at its June 8, 2021 annual meeting of stockholders. 